JPMorgan Chase & Co. Has $429,000 Stock Holdings in Ultralife Co. (NASDAQ:ULBI)

JPMorgan Chase & Co. grew its stake in shares of Ultralife Co. (NASDAQ:ULBI - Free Report) by 250.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 47,458 shares of the technology company's stock after acquiring an additional 33,929 shares during the period. JPMorgan Chase & Co. owned 0.29% of Ultralife worth $429,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of ULBI. Dimensional Fund Advisors LP increased its position in Ultralife by 5.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,024,491 shares of the technology company's stock worth $10,880,000 after purchasing an additional 51,399 shares during the last quarter. Janney Montgomery Scott LLC lifted its stake in Ultralife by 2.4% in the third quarter. Janney Montgomery Scott LLC now owns 443,150 shares of the technology company's stock valued at $4,006,000 after acquiring an additional 10,450 shares during the last quarter. Renaissance Technologies LLC grew its position in Ultralife by 9.1% in the second quarter. Renaissance Technologies LLC now owns 242,490 shares of the technology company's stock worth $2,575,000 after acquiring an additional 20,300 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Ultralife by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 232,681 shares of the technology company's stock valued at $2,104,000 after purchasing an additional 2,835 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Ultralife by 15.5% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 157,330 shares of the technology company's stock worth $1,422,000 after purchasing an additional 21,140 shares in the last quarter. 30.68% of the stock is owned by institutional investors and hedge funds.

Ultralife Stock Performance

Shares of Ultralife stock traded down $0.02 during trading on Thursday, reaching $7.75. The company's stock had a trading volume of 22,732 shares, compared to its average volume of 46,676. The business's fifty day moving average price is $7.65 and its 200-day moving average price is $8.94. Ultralife Co. has a one year low of $6.63 and a one year high of $13.39. The firm has a market cap of $128.88 million, a price-to-earnings ratio of 14.09 and a beta of 0.96. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.62 and a current ratio of 3.30.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ULBI. Benchmark reiterated a "buy" rating and set a $14.00 price target on shares of Ultralife in a research note on Friday, November 15th. StockNews.com lowered shares of Ultralife from a "strong-buy" rating to a "buy" rating in a research report on Thursday, October 3rd.

Ultralife Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.